Goldman Sachs just named a specific Kospi target that would make South Korean equities among the biggest winning trades of the decade, but it hinges on two chip giants delivering something the market has never quite seen before.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
FIX, GS, VRT, STX and TRV are five momentum stocks for August as AI infrastructure, financial strength and earnings growth support their outlooks.
Goldman Sachs Group (NYSE:GS) premium income ETFs, GPIX and GPIQ, are currently outperforming JPMorgan’s JEPI and JEPQ across expense ratios, dividend yields, and total returns. The comparison highlights competitive advantages for Goldman Sachs products in the premium income ETF category. The performance gap has drawn attention to Goldman Sachs as a growing player in retail income-focused ETFs. Goldman Sachs Group has long been known for its institutional and advisory businesses, and its...
(Bloomberg) -- The momentum trade just gave investors a taste of the pronounced profit-and-loss swings they can expect if they fail to hedge or diversify, a warning that’s reinforced by growing inflation risks. Most Read from BloombergTrump Says US to Hold Off Iran Attack If Deal AgreedSaudi Prince Concerned Over Trump’s Iran Strike Plan: AxiosTrump Says Iran Talks to Begin Monday After Scrapping AttackSingapore's Gated Island for the Rich Is Marred by Decayed HomesAlibaba Adds to China AI Break
Apple just posted its strongest June quarter ever and surged double digits, yet one popular income ETF built around Nasdaq-100 giants moved in the opposite direction. Understanding why reveals a hidden cost that never appears on the fund's expense-ratio line.
Financial stocks like XLF, JPMorgan, and Bank of America hit new highs on strong Q2 earnings as investors rotate out of technology, though bank shares pulled back ahead of the Fed meeting.
Financial stocks have been among the market’s best performers this month. The Fed’s next move, however, may determine how much further the rotation can run.
Robinhood Markets (Nasdaq: HOOD) reported its earnings for the second quarter of 2026 on July 29. The brokerage platform, popular for its equity, crypto, and tokenized stock offerings, generated $1.31 billion in revenue and $0.62 in earnings per share (EPS), beating Wall ...
Goldman Sachs advised on transactions worth $437.7bn, while Houlihan Lokey ranked first by volume with 104 deals.
Goldman Sachs Group (NYSE:GS) has launched a new private markets platform aimed at wealthy clients, expanding access to alternative investments. Goldman Sachs Alternatives has agreed to acquire AEGIS Hedging Solutions, a provider of risk management and hedging services. For investors watching how Goldman Sachs Group positions itself beyond traditional investment banking, these two moves sit squarely in its asset and wealth management efforts. A broader private markets platform for high net...
Alphabet, MasTec and Goldman Sachs topped a momentum screen built on the Driehaus strategy, combining earnings strength with favorable price trends.
(Bloomberg) -- Scribe Therapeutics Inc., a clinical-stage developer of gene therapies for heart diseases, surged 67% on Friday after raising $128.7 million in an upsized initial public offering.Most Read from BloombergRetina Chip Designed to Restore Sight to Go on Sale in EuropeHegseth Turns to UNC, Virginia Tech After Dropping Ivy LeagueApple Plans Overhaul of MacBooks, iMac in Push to Meet AI DemandTrump Rebuilds Tariffs With New Levies on 60 EconomiesSpaceX Turns Away Falcon Customers in Majo
President Donald Trump’s threat of 100% tariffs on generic drugs would seem to be a problem for Teva Pharmaceutical. It might not be.
Does Goldman Sachs (GS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Earlier in July 2026, Goldman Sachs reported strong second-quarter results, with net income rising to US$6.63 billion and earnings per share roughly doubling year-on-year. Alongside these results, Goldman Sachs intensified capital return and funding actions, including billions in new bond and preferred issuances plus continued buybacks and a higher quarterly dividend. We’ll now examine how this combination of record earnings and increased capital returns might influence Goldman Sachs’...
JPM, GS and C stand out after strong Q2 results, upbeat 2026 outlooks and improving earnings estimates.
(Bloomberg) -- One of the most enduring foreign-exchange bets is off to its best run in decades as surprisingly muted volatility across asset classes has investors piling into carry trades.Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeUS Strikes Iran in Escalating Campaign After Troo
(Bloomberg) -- Moonshot AI has told investors it’s preparing to list in as early as six months, seizing the opportunity to tap capital markets after its latest model upended industry perceptions of China’s burgeoning capabilities and sent global tech stocks reeling.Most Read from BloombergFCC Near Rulings Against Disney Over ‘The View,’ TV LicensesUS Strikes Iran to ‘Punish’ It for Attack That Killed 2 TroopsThousands of Trucks Haul Iraq’s Oil Through Syria in Sign of Hormuz LegacyTaylor Farms P
Analysts also report on Mattel, Cadence Design Systems, DraftKings, Travel + Leisure, and CrowdStrike.
P, UI, JPM, GS and C have been added to the Zacks Rank #1 (Strong Buy) List on July 17, 2026.
📈 Follow our live markets data and coverage. It was an epic quarter for investment banks. Goldman Sachs said this week that its stock-trading revenue hit a record $7.4 billion, up 72% from a year earlier.
TXN, JPM and GS made it to the Zacks Rank #1 (Strong Buy) income stocks list on July 17, 2026.
IBM's weak preliminary Q2 results erased $55 billion in market value. But Wall Street remains divided on whether Big Blue can stage a comeback.
JPMorgan Chase is Wednesday's IBD Stock Of The Day after blowout earnings. Intraday, JPMorgan Chase stock rose in a buy zone and cleared an alternate entry. Other Big Bank stocks continued to rally as analysts raised their outlook for the sector.
Morgan Stanley's Q2 earnings surge 62.4% as record equity revenues, stronger IB and $10T in client assets fuel growth. MS raised its quarterly dividend 15%.